Combining addiction and infectious disease services in rural primary care
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings
This study is looking to make it easier for people in rural West Virginia to get help for addiction and diseases like HIV and hepatitis C right at their local doctor's office, so they can receive the care they need in a friendly and supportive environment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10864966 on NIH RePORTER |
What this research studies
This research aims to integrate services for addiction and infectious diseases, particularly HIV and hepatitis C, into primary care settings in rural areas. It focuses on West Virginia, where the opioid epidemic has led to increased rates of HIV outbreaks. The approach involves screening and evaluating patients for opioid use disorder and HIV, followed by appropriate treatment using evidence-based practices. By enhancing the capabilities of primary care clinics, the research seeks to improve health outcomes for patients in these underserved regions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in rural areas who are at risk for or currently affected by HIV and opioid use disorder.
Not a fit: Patients who do not reside in rural areas or who are not at risk for HIV or opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment of HIV and opioid use disorder in rural communities.
How similar studies have performed: Previous research has shown success in integrating addiction and infectious disease services in urban settings, but this approach in rural areas is relatively novel.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Altice, Frederick Lewis — Yale University
- Study coordinator: Altice, Frederick Lewis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.